JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John G. Coles
William G. Williams
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedra, C. A. C.
Right arrow Articles by Benson, L. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedra, C. A. C.
Right arrow Articles by Benson, L. N.
Related Collections
Right arrow Congenital - cyanotic
Right arrow Valve disease

J Thorac Cardiovasc Surg 2002;124:82-87
© 2002 The American Association for Thoracic Surgery


Surgery for Congenital Heart Disease (CHD)

Percutaneous stent implantation to stenotic bioprosthetic valves in the pulmonary position

Carlos A. C. Pedra, MD*, Henri Justino, MD, FRCPC**, David G. Nykanen, MD, FRCPC, Glen VanArsdell MD, FRCSC, John G. Coles, MD, FRCSC, William G. Williams, MD, FRCSC, Robert M. Freedom, MD, FRCPC, Lee N. Benson, MD, FRCPC

From the Department of Pediatrics and Surgery, Division of Cardiology, The Variety Club Catheterization Laboratories, and the Division of Cardiovascular Surgery, The Hospital for Sick Children, The University of Toronto School of Medicine, Toronto, Ontario, Canada.

Received for publication May 11, 2001. Revisions requested Oct 1, 2001; revisions received Nov 14, 2001. Accepted for publication Nov 28, 2001. Address for reprints: Lee Benson, MD, FRCPC, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, M5G 1X8, Canada (E-mail: benson{at}sickkids.on.ca).

Background: We evaluated stent implantation across stenotic bioprosthetic pulmonary valves in 9 patients.
Methods: Nine patients (6 male patients) underwent stent implantation across stenotic bioprosthetic pulmonary valves between July 1996 and July 1999 at the Hospital for Sick Children, Toronto. Catheter intervention was indicated if echocardiography revealed Doppler estimates of right ventricular pressure of more than two thirds of systemic arterial pressure (or systolic septal flattening with an estimated gradient of >60 mm Hg across the valve prosthesis). Catheterization was performed during general anesthesia at an age (mean ± SD) of 9.3 ± 3.5 years and a weight of 32.0 ± 17.1 kg 5.9 ± 1.8 years after surgical insertion of a bioprosthetic valve in the pulmonary position: 7 patients with tetralogy of Fallot, 1 patient with congenital pulmonary stenosis-insufficiency, and 1 patient after a Rastelli operation. All had systolic septal flattening and right ventricular dilatation with moderate-to-severe pulmonary insufficiency before intervention. Fluoroscopy times were 33.1 ± 9.5 minutes. Seven patients received a single P4014 stent, and 2 received single P308 stents (Palmaz; Johnson & Johnson Interventional Systems, Warren, NJ) without significant complications.
Results: The right ventricular systemic pressure decreased acutely from 83% ± 16% to 41% ± 10% (P < .001, n = 9), and the transvalvular gradient decreased from 49.7 ± 8.5 to 11.0 ± 5.9 mm Hg (P < .001, n = 8). During the follow-up period (10.9 ± 8.1 months, n = 8), 1 patient had an unsuccessful attempt at redilation of the stent (right ventricular pressure, 60% systemic) and underwent uneventful surgical pulmonary valve replacement. None of the remaining patients had echocardiographic evidence of systolic septal flattening, and right ventricular dimensions did not change significantly.
Conclusion: Stent implantation is a safe and effective means of providing palliative relief of obstructed bioprosthetic valves in the pulmonary position and can safely delay the requirement for pulmonary valve replacement.




This article has been cited by other articles:


Home page
CirculationHome page
S. Khambadkone, L. Coats, A. Taylor, Y. Boudjemline, G. Derrick, V. Tsang, J. Cooper, V. Muthurangu, S. R. Hegde, R. S. Razavi, et al.
Percutaneous Pulmonary Valve Implantation in Humans: Results in 59 Consecutive Patients
Circulation, August 23, 2005; 112(8): 1189 - 1197.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H Sugiyama, W Williams, and L N Benson
Implantation of endovascular stents for the obstructive right ventricular outflow tract
Heart, August 1, 2005; 91(8): 1058 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. I. Turina
Future of heart valve surgery
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(Suppl_1): S8 - S13.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Q. Zhou, A. F. Corno, C. H. Huber, P. Tozzi, and L. K. von Segesser
Self-expandable valved stent of large size: off-bypass implantation in pulmonary position
Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 212 - 216.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.